Xenex Disinfection Services filed a De Novo petition with the U.S. Food and Drug Administration (“FDA”) for medical device market authorization of its LightStrike+ ultraviolet (UV) room disinfection technology. The company’s patented device uses a xenon lamp to create broad spectrum UV light intended to quickly destroy pathogens on surfaces in healthcare facilities. Xenex‘s LightStrike technology is currently being sold…
Xenex Makes De Novo Petition to FDA for LightStrike UV Room Disinfection Technology
More from InformationalMore posts in Informational »
- Misleading Readings: Pitfalls in UV Radiometry
- Multi-spectral Analysis Discovers Another Joan Miro Painting Underneath Known One
- Portage Suberb Of Chicago Updating UV Equipment At Water Treatment Plant
- Numerous Snake Species Emit UV Wavelengths For Species Interaction
- Guyana Water Purification Initiative Includes Use Of UV Irradiation And Science Education On Its Operational Principles